Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-28 @ 9:47 AM
Study NCT ID:
NCT01462357
Status:
COMPLETED
Last Update Posted:
2019-11-15
First Post:
2011-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2015-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-27
First Submit QC Date:
None
Study First Post Date:
2011-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-11
Results First Submit QC Date:
None
Results First Post Date:
2016-03-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-30
Last Update Post Date:
2019-11-15
Last Update Post Date Type:
ACTUAL